ATM mutations in cancer families

Cancer Research

Volumn 56, Issue 18, 1996, Pages 4130-4133

  Vořechovský, Igor ^a,b   Luo, Liping ^a   Lindblom, Annika ^c   Negrini, Massimo ^d   Webster, A David B ^b   Croce, Carlo M ^d   Hammarström, Leimart ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; ATAXIA TELANGIECTASIA; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE; CHROMOSOME 11Q; DNA DAMAGE; DNA POLYMORPHISM; FAMILIAL CANCER; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADENINE; ALLELES; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DNA-BINDING PROTEINS; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MALE; NEOPLASMS; PEDIGREE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POINT MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; SEQUENCE DELETION; THYMINE; TUMOR SUPPRESSOR PROTEINS;

EID: 0029832291     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Shiloh, Y. Ataxia-telangiectasia: closer to unraveling the mystery. Eur. J. Hum. Genet., 3: 116-138, 1995
2. Gatti, R. A , Berkel, I., Boder, E , Braedt, G., Charmley, P., Concannon, P., Ersoy, F., Foroud, T , Jaspers, N. G. J., Lange, K., Lathrop, G. M., Leppert, M., Nakamura, Y. Y , O'Connel, P., Paterson, M., Salser, W., Sanal, O., Silver, J., Sparkes, R. S , Susi, E., Weeks, D. E., Wei, S., White, R., and Yoder, F. Localization of an alaxia-telangiectasia gene to chromosome 11q22-23. Nature (Lond.), 336: 577-580, 1988.
3. Savitsky, K., Bar-Shira, A , Gilad, S., Rotman, G., Ziv, Y , Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T , Sfez, S , Ashkenazi, M., Pecker, I , Frydman, M., Harnik, R., Patanjali, S R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N G J., Taylor, A. M. R., Arlett, C. F., Miki, T , Weissman, S. M., Lovett, M , Collins, F. S., and Shiloh, Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase Science (Washington DC), 268: 1749-1753, 1995.
4. Savitsky, K., Sfez, S., Tagle, D. A., Ziv, Y., Sartiel, A., Collins, F. S., Shiloh, Y., and Rotman, G. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators m different species. Hum. Mol. Genet., 4: 2025-2032, 1995
5. Zakian, V. A. ATM-related genes: what do they tell us about functions of the human gene? Cell, 82 685-687, 1995.
6. Morrell, D , Cromartie, E., and Swift, M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J. Natl. Cancer Inst., 77: 89-92, 1986
7. Taylor, A. M. R. Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma, and breast cancer. Br. J. Cancer, 66: 5-9, 1992.
8. Swaft, M., Reitnauer, P. J., Morrell, D., and Chase, C L. Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med , 316: 1289-1294, 1987.
9. Swift, M , Morrell, D , Massey, R B , and Chase, C. L Incidence of cancer in 161 families affected by ataxia-telangiectasia N. Engl. J. Med , 325: 1831-1836, 1991
10. Pippard, E. C , Hall, A J., Barker, D J. P., and Bridges, B A Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res., 48: 2929-2932, 1988.
11. Bøsrresen, A-L , Andersen, T I , Tretli, S , Heiberg, A , and Møller, P. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosomes & Cancer, 2: 339-340, 1990.
12. Easton, D F. Cancer risk in A-T heterozygotes Int. J Radiat Biol , 66: 177-182, 1994.
13. Rasio, D., Negrini, M , and Croce, C. M. Genomic organization of the ATM locus involved in ataxia-telangiectasia. Cancer Res , 55: 6053-6057, 1995.
14. Vořechovský, I., Rasto, D., Luo, L., Monaco, C., Hammarstrom, L , Webster, A. D. B., Zaloudik, J , Barbanti-Brodano, G , James, M , Russo, G , Croce, C. M., and Negrini, M. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res , 56: 2726-2732, 1996.
15. Uziel, T., Savitsky, K , Platzer, M , Ziv, Y., Helbitz, T., Nehls, M., Boehm, T , Rosenthal, A., Shiloh, Y., and Rotman, G. Genomic organization of the ATM gene. Genomics, 33: 317-320, 1996.
16. Vořechovský, I , Vihinen, M , de Saint Basile, G., Honsová, S , Hammarstrom, L., Müller, S , Nilsson, L , Fischer, A., and Smith, C. I E. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agamma-globulinaemia. Hum. Mol. Genet., 4: 51-58, 1995.
17. Hayashi, K PCR-SSCP: single-strand conformation polymorphism analysis of PCR products In: U Landegren (ed ), Laboratory Protocols for Mutation Detection, pp. 14-22. Oxford, United Kingdom: Oxford University Press, 1996.
18. Gilad, S., Khosravi, R., Shkedy, D., Uziel, T , Ziv, Y., Savitsky, K., Rotman, G., Smith, S., Chessa, L., Jorgensen, T. J , Harnik, R., Frydman, M., Sanal, O., Portnoi, S , Goldwicz, Z , Jaspers, N. G. J., Gatti, R. A., Lenoir, G., Lavin, M. F., Tatsumi, K., Wegner, R. D., Shiloh, Y., and Bar-Shira, A. Predominance of null mutations in ataxia-telangiectasia Hum. Mol Genet., 5: 433-439, 1996.
19. Byrd, P. J., McConville, C. M., Cooper, P., Parkhill, J., Stankovic, T., McGuire, G. M., Thick, J. A., and Taylor, A. M. R Mutations revealed by sequencing the 5′ half of the gene for ataxia-telangiectasia. Hum Mol Genet., 5: 145-149, 1996.
20. Wood, C. G., Bundey, S. E., and Taylor, A M. R. Unusual features in the inheritance of ataxia-telangiectasia. Hum. Genet , 84: 555-557, 1990.
21. Wooster, R., Ford, D., Mangian, J., Ponder, B A. J , Peto, J., Easton, D. F , and Stratton, M R. Absence of linkage 10 the ataxia telangiectasia locus m familial breast cancer. Hum. Genet., 92: 91-94, 1993.
22. Cortessis, V., Ingles. S., Millikan, R., Diep, A., Gatti, R. A., Richardson, L., Thompson, W. D., Paganini-Hill, A., Sparkes, R. S , and Haile, R. W. Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene in 64 families with premenopausal bilateral breast cancer. Cancer Res., 53: 5083-5086, 1993.
23. Lander, E. S., and Schork, N. J. Genetic dissection of complex traits. Science (Washington DC), 265: 2037-2048, 1994
24. Lander, E. S., and Schork, N. J Genetic dissection of complex traits. Correction. Science (Washington DC), 266: 353, 1994.
25. Carter, S. L., Negrini, M , Baffa, R., Gillum, D R., Rosenberg, A. L., Schwartz, G F , and Croce, C. M. Loss of heteroxygosity at 11q22-q23 in breast cancer. Cancer Res., 54: 6270-6274, 1994.
26. Hampton, G. M., Mannermaa, A., Winquist, R., Alavaikko, M., Blanco, G., Taskinen, P. J , Kivintermi, H., Newsham, I , Cavenee, W. K., and Evans, G. A. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res., 54: 4586-4589, 1994.
27. Gudmundsson, J., Barkardottir, R. B., Eiriksdottir, G., Baldursson, T., Arason, A., Egilsson, V , and Ingvarsson, S. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br. J. Cancer, 72: 696-701, 1995.
28. Winquist, R., Hampton, G. M., Mannermaa, A., Blanco, G., Alavaikko, M., Kivimemi, H , Taskmen, P. J., Evans, G A , Wright, F. A., Newsham, I , and Cavenee, W. K. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res., 55: 2660-2664, 1995.
29. Tomlinson, I. P. M , Stickland, J. E , Lee, A S. G., Bromley, L., Evans, M. F., Morton, J., and Mcgee, J. O. Loss of heterozygosity on chromosome 11q in breast cancer. J Clin. Pathol. (Lond.), 48: 424-428, 1995.
30. Negrini, M., Rasio, D., Hampton, G. M , Sabbioni, S , Rattan, S., Carter, S. L., Rosenberg, A. L., Schwartz, G. F , Shiloh, Y., Cavenee, W. K., and Croce, C. M. Definition and refinement of chromosome 11 regions of LOH in breast cancer: identification of a new region at 11q23-q24. Cancer Res , 55, 3003-3007, 1995.
31. Gabra, H., Watson, J. E. V., Taylor, K J , Mackay, J., Leonard, R. C F , Steel, C. M., Porteous, D. J , and Smyth, J F. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res , 56: 950-954, 1996.
32. Davis, M , Hitchcock, A , Foulkes, W. D., and Campbell, I. G. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res., 56: 741-744, 1996.
33. Savitsky, K., Ziv, Y., Bar-Shira, A., Gilad, S , Tagle, D. A , Smith, S , Uziel, T., Sfez, S , Nahmias, J., Sartiel, A., Eddy, R L , Shows, T. B., Collins, F. S., Shiloh, Y., and Rotman, G A human gene (DDXlO) encoding a putative DEAD-box RNA helicase at 11q22-q23. Genomics, 33: 199-206, 1996
34. Beaudet, A L , and Tsui, L-C. A suggested nomenclature for designating mutations. Hum Mutat , 2 245-248, 1993